Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 950200

Psomagen, Inc.

Official website

KOSDAQ-listed genomics company offering NGS, single-cell, and proteomics analysis plus the Kean Gene DTC genetic test.

As of 2026-10-08, Psomagen, Inc. has 9 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2004 and listed on KOSDAQ in 2020, Psomagen is a genomics analysis service company. It offers next-generation sequencing (NGS) and capillary electrophoresis sequencing (CES)-based genomic analysis, the direct-to-consumer genetic test Kean Gene, single-cell analysis, proteomics analysis, and the C9orf72 Assay for neurological disease genes. It obtained CSP certification from 10x Genomics, NanoString, and Sweden's Olink Proteomics, adopting the Chromium X, CosMx, and Q100 platforms respectively; it commercialized clinical whole-transcriptome analysis in collaboration with Mindera Health of the US; and it plans to complete development of 15 WES/WGS-based cancer panels, including a Hereditary Cancer Panel, within 2026.

Products & technology

  • NGS analysis serviceWhole-genome/exome, RNA/transcriptome, single-cell, and metagenomics analysis
  • CES analysis serviceCapillary electrophoresis sequence verification
  • Kean GeneDirect-to-consumer genetic test
  • Single-cell analysis serviceSingle-cell gene expression analysis
  • Proteomics analysis serviceProtein-based biomarker analysis (Targeted panel, Explore service)
  • C9orf72 AssayAnalysis of the C9orf72 gene linked to frontotemporal dementia and ALS

R&D and key agreements

Source: DART corporate disclosure

유전성 망막질환 패널 · 유전성 망막질환 · 개발완료, 서비스 준비중 · Plan shifted from panel-based testing to WGS/WES-based diagnostics

Cancer Panel(Hereditary Cancer Panel 등 15개 패널) · 유전성 암 등 · 개발중, 2026년 내 개발완료 예상 · WES/WGS-based

Targeted Panel 분석기술 · 연구용 유전자 분석 · 연구서비스 제공중

임상 전장전사체분석 · 연구 및 진단 · 상용화 완료 · Developed with Mindera Health (US) under a distributive assay model

인종별 장내미생물군 데이터베이스 · 마이크로바이옴 · 구축중 · Uses whole meta-genome sequencing

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 72 more patents

AI reads

MAA server logs · IP-verified
29
Times AI engines pulled Psomagen, Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

29
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

5
live 0
Last 7 days
22
live 0
Last 30 days
29
live 0
All time
  • OpenAIOAI-SearchBot25
  • AnthropicClaudeBot2
  • GoogleGoogleOther1
  • PerplexityPerplexityBot1

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 6, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Psomagen, Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryBiotech & Drug Discovery

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

Inventage Lab Inc.100

Drug delivery system company behind the long-acting injectable platform IVL-DrugFluidic and the LNP delivery platform IVL-GeneFluidic.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

SK Chemicals Co., Ltd.85

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

CG Invites Co., Ltd.85

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

Y-Biologics, Inc85

KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.

GC Corp.85

A holding company overseeing 54 affiliates including its main biopharmaceutical subsidiary GC, with no direct product manufacturing of its own.

Prestige BioPharma Limited85

Founded in 2015 and listed on KOSPI in 2021, Prestige BioPharma develops antibody biosimilars and novel antibody drugs including Tuznue.

GENEMATRIX INC.85

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

SillaJen, Inc.85

SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.

SK Bioscience Co.,Ltd84

A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition